How much funding has Sai Advantium Pharma raised?

Sai Advantium Pharma has raised $135.0M in total funding, most recently a Private Equity round.

Who are Sai Advantium Pharma's investors?

Sai Advantium Pharma's investors include TPG (Growth/Rise), Tata Capital Innovations Fund.

When was Sai Advantium Pharma founded?

Sai Advantium Pharma was founded in 1999.

Where is Sai Advantium Pharma headquartered?

Sai Advantium Pharma is headquartered in Telangana, India.

What industry is Sai Advantium Pharma in?

Sai Advantium Pharma operates in Healthcare, Biotech.

How many employees does Sai Advantium Pharma have?

Sai Advantium Pharma has 1001-5000 employees.

Sai Advantium Pharma

IPO

Public · Telangana, India · Founded 1999 · $135.0M raised

Healthcare

Biotech

Headquarters: Telangana
Employees: 1001–5000
Founded: 1999
Business Model: B2B
Website: sailife.com

Total Funding: $135.0M
Last Round: $135.0M Private EquityJan 2018
Rounds: 2
Type: Public

About

Sai Advantium Pharma, now operating as Sai Life Sciences, is a full-service contract research, development, and manufacturing organization (CRDMO) headquartered in Hyderabad, India. Founded in 1999, it partners with over 280 global innovator pharma and biotech companies to accelerate small molecule drug discovery, development, and commercial manufacturing. The company employs 3,400+ scientists across facilities in India, the UK, and the USA and is listed on BSE and NSE (ticker: SAILIFE).

Summary

Sai Advantium Pharma is a Healthcare company based in Telangana, India, founded in 1999. It has raised $135.0M in total across 2 rounds, most recently a $135.0M Private Equity round in Jan 2018. Investors include TPG (Growth/Rise) and Tata Capital Innovations Fund.